Back to the Top
The following message was posted to: PharmPK
Dear All:
After a bioequivalence study performed on a delayed release oral product,which could be the regulatory impact if a change in manufacturing equipment is needed (direct heating, static solids bed versus direct heating, fluidized solids bed /same class, different subclass)
Thanking in advance
Nelida Mondelo
R&D Manager, R&D
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Bioequivalence with changed manufacturing" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)